Wnt-11 is found to be upregulated in metastatic disease, and more importantly, it has been shown that it involves in TGF-β signaling pathways during the epithelial-to-mesenchymal transition (EMT), which is important for prostate cancer cell migration and invasion [13]. Here, WNT11 is linked to prostate carcinoma.